Combination antiplatelet agents for secondary prevention of ischemic stroke. (Q37281572)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823219%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

review article

1 reference

title

Combination antiplatelet agents for secondary prevention of ischemic stroke (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823219%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823219%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Joseph P Vande Griend

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823219%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

1 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823219%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823219%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823219%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823219%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

1233-1242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823219%20AND%20SRC:MED&resulttype=core&format=json

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Dipyridamole plus aspirin for stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Dipyridamole plus aspirin in cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Dipyridamole bioavailability in subjects with reduced gastric acidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

How much esprit is in ESPRIT?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Emerging therapies: ESPRIT

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in coll

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Dipyridamole and headache--a pilot study of initial dose titration

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Dose titration to reduce dipyridamole-related headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

Prospects for the prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1233

21 January 2018

Identifiers

DOI

10.1592/PHCO.28.10.1233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18823219%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference